117
Novo Nordisk A/S Sponsored ADR
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions DKK
FY21:
FY22:
149
FY23:
196
FY24:
246
FY25:
250
(positive)
Change from FY21 to FY25
billions DKK
FY21:
58.6
FY22:
74.8
FY23:
103
FY24:
128
FY25:
128
(positive)
Change from FY21 to FY25
billions DKK
FY21:
64.8
FY22:
82.0
FY23:
113
FY24:
–
FY25:
151
(positive)
Change from FY21 to FY25
billions DKK
FY21:
59.1
FY22:
69.1
FY23:
105
FY24:
127
FY25:
131
(positive)
Change from FY21 to FY25
billions DKK
FY21:
47.8
FY22:
55.5
FY23:
83.7
FY24:
101
FY25:
102
All amounts in billions DKK